1. Prof. O. Sartor – Medical Director: Tulane Cancer Center, New Orleans, USA.

2. Prof. R. Reis – Molecular Oncology Research Center, Barretos Cancer Hospital, Brazil; Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal.

3. Prof. D. Bates – Director: Centre for Cancer Sciences, University of Nottingham, UK.

4. Prof. H. Yu – University of Hawaii Cancer Center, Honolulu, Hawaii, USA.

5. Prof. N. Kim – University of Ulsan, Seoul, South Korea.

6. Prof. H. zur Hausen – DKFZ German Cancer Research Center, Heidelberg, Germany.

7. Prof. A. Chatziioannou – Center of Systems Biology, Biomedical Research Foundation Academy of Athens, Athens, Greece; e-NIOS Applications PC, Kallithea, Athens, Greece.

8. Dr. B. Reddy – Chief Medical Officer, ImmunityBio Inc. Los Angeles, California, United States.

9. Prof. M. Foiani – Scientific Director of the FIRC Institute of Molecular Oncology Foundation (IFOM), Milan, Italy.

10. Prof. R. Mehrotra – Centre for Health Innovation and Policy (CHIP) Foundation and Datar Cancer Genetics (DCG), India.

11. Prof A.M. Kaufmann – Universität zu Berlin, Berlin Institute of Health, Germany.

12. Prof. M. Bedford – Co-Director, Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

13. Dr. L. Cantley – Dana-Farber / Harvard Cancer Center (DF/HCC), Boston, Massachusetts, USA.